To date, the IHC evaluation of KIT expression has been limited to a semi-quantitative evaluation, expressed as classes corresponding to an approximate percentage of immunoreactive cells on the total tumor area, often with wide ranges defining a single class [34,39]. This evidence concerns the gene KIT and neoplasm.